Media and Press

AUSTIN, Texas – August 18, 2021 – e2open (NYSE: ETWO), a network-based provider of cloud-based, mission-critical, end-to-end supply chain management software, today announced the release of its third-quarter technology update for the year, with a wide range of enhancements to help clients further leverage e2open’s multi-enterprise network to make more connected business decisions. Connected decisions improve resiliency and agility by going beyond internal organizational boundaries to reflect the current supply chain realities of external partners. 

Soybeans are a high-volume commodity, especially for China, the largest importer of soybeans in the world. China imports around 90% of its soybeans from the United States, Brazil and a few other nations. In the first six months of 2021, China imported a record 48.95 million tons, up nearly nine percent over last year. The U.S. Department of Agriculture (USDA) Foreign Agricultural Service reported that global soybean exports reached record levels, grossing the second-highest value ever at $7.7 billion.

My last blog post about artificial intelligence (AI) covered some of the technology’s history, including how engineers, scientists, writers and readers all understood the rise of AI would change everything.

Sales channels have always been evolving. Historically there were middlemen. More recently, there were influencers. Now, the world is entering the third age of channels: the ecosystems. Each age builds on the previous one, adding new nuances, models and demands at an accelerating speed. Businesses that understand this evolution and embrace or even drive it stand to gain a first-mover advantage and capture customers and partners alike.

AUSTIN, Texas — August 5, 2021 — E2open (NYSE: ETWO), a leading network-based provider of cloud-based, mission-critical, end-to-end supply chain management software, announces a strategic relationship with Vizient, Inc., the largest healthcare performance improvement company in U.S., to develop a new platform to increase trust, transparency and predictability for its member health systems. 

Modernizing your supply chain is a worthy goal, and for pharmaceutical and life science companies, a big part of modernization is to outsource manufacturing and other business functions to various trading partners across the supply chain. There are many good reasons to do so. Benefits include cost savings, efficiency, specialized manufacturing capabilities and operational productivity enhancements. Companies should evaluate their core competencies and outsource where it makes the most business sense.

Hearing the unwelcome words, “You’re going to be audited,” always sends folks into a frenzy and a flurry of activity. Customs organizations all around the globe have become more and more explicit about their intent to audit every exporter and importer at some point in time.

If your company engages in global trade, you know that you have no choice but to screen every party to an export transaction. Government agencies require you to “know your customer”— as well as the banks, carriers and freight forwarders in your logistics ecosystem.

Change is good but often challenging. This is especially true when massive changes occur to regulatory data that affect international commerce. Yet a mammoth change in regulatory guidance occurs every five years that affects everyone moving goods globally.